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Abstract
Purpose Quantitative assessment of white matter
hyperintensities (WMH) on structural Magnetic Resonance
Imaging (MRI) is challenging. It is important to harmonise
results from different software tools considering not only the
volume but also the signal intensity. Here we propose and
evaluate a metric of white matter (WM) damage that addresses
this need.
Methods We obtained WMH and normal-appearing white
matter (NAWM) volumes from brain structural MRI from
community dwelling older individuals and stroke patients en-
rolled in three different studies, using two automatic methods
followed by manual editing by two to four observers blind to
each other. We calculated the average intensity values on brain
structural fluid-attenuation inversion recovery (FLAIR) MRI
for the NAWMandWMH. The white matter damagemetric is
calculated as the proportion of WMH in brain tissue weighted
by the relative image contrast of the WMH-to-NAWM. The
new metric was evaluated using tissue microstructure param-
eters and visual ratings of small vessel disease burden and
WMH: Fazekas score for WMH burden and Prins scale for
WMH change.
Results The correlation between the WM damage metric and
the visual rating scores (Spearman ρ > =0.74, p < 0.0001) was
slightly stronger than between the latter and WMH volumes
(Spearman ρ > =0.72, p < 0.0001). The repeatability of the
WM damage metric was better than WM volume (average
median difference between measurements 3.26% (IQR
2.76%) and 5.88% (IQR 5.32%) respectively). The follow-
up WM damage was highly related to total Prins score even
when adjusted for baseline WM damage (ANCOVA,
p < 0.0001), which was not always the case forWMH volume,
as total Prins was highly associated with the change in the
intense WMH volume (p = 0.0079, increase of 4.42 ml per
unit change in total Prins, 95%CI [1.17 7.67]), but not with the
change in less-intense, subtle WMH, which determined the
volumetric change.
Conclusion The new metric is practical and simple to calcu-
late. It is robust to variations in image processing methods and
scanning protocols, and sensitive to subtle and severe white
matter damage.
Keywords MRI . Brain . Cerebrovascular disorders .
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Abbreviations
WMH White matter hyperintensities
FLAIR Fluid Attenuated Inversion Recovery
MRI Magnetic resonance imaging
NAWM Normal-appearing white matter
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Introduction
White matter hyperintensities (WMH) are a common neuro-
radiological finding detected in T2-weighted (T2W) and fluid
attenuation inversion recovery (FLAIR) structural magnetic
resonance images (MRI) in older individuals and patients with
neurological diseases [1]. Their growing importance reflects
the increasing recognition of their association with a wide
range of disabilities [2], vascular risk factors [3] and impair-
ments in activities of daily living [4]. Different visual rating
scales are available [5–10] to assess their frequency, extent in
various locations and progression [11]. However, inter- and
intra-observer variation in visual assessments [12] have moti-
vated development of computational methods for WMH bur-
den quantification. With widespread availability of MRI tech-
nologies, there is growing expectation of incorporating these
computational methods into diagnostic software.
The current literature onmethods to quantifyWMH burden
and progression is large [13, 14]. Semi-automated or automat-
ed methods are thought to be sensitive and reproducible, but
very few have been compared directly with each other, or with
visual scores. Furthermore, errors in tissue classification, in
exclusion or not of artefacts, and in manual correction of
computer-generated masks have largely not been assessed
but probably contribute to inconsistencies in results of studies
of WMH associations [13]. In most cases, the computational
requirements to run the most up-to-date fully automatic seg-
mentation techniques are not specified, nor the processing
time, which could be many hours for a single dataset. So far,
most large clinical or population studies have used conven-
tional histogram-based thresholding of FLAIR images to as-
sess WMH volume (see Supplementary Table from [13]),
mainly owed to its simplicity, minimal resource requirements
and relative speed, and, perhaps for these reasons, there is a
growing tendency to base assessment of new WMH quantifi-
cation techniques on this approach. However, FLAIR-only
derived thresholds are significantly affected by the WMH sig-
nal strength, anatomical distribution, extent [15] and technical
factors such as bias field correction [13].
Subtle FLAIR/T2WWMH have received special attention
as they may indicate pre-lesional tissue changes [16], but are
difficult to quantify as theymay extend over large regions, and
lack a clear boundary [13]. Thus they often appear included in
Bnormal-appearing^ white matter (NAWM). NAWM is de-
fined as having intensities from 50 to 75% of the maximum
intensity value on a T2 W-based sequence (e.g. T2 W and/or
FLAIR), and are coincident with the regions classed as white
matter on the human brain atlas (http://www.thehumanbrain.
info/), after excluding stroke lesions and WMH [17]. When
the signal strength of the WMH is high, then subtle (‘pre-
lesional’) WMH could be classed as Bnormal^ tissue and,
therefore, disregarded from an evolving pathological process.
Hence, it may be necessary to weight the quantitative WMH
volumes (obtained from any quantification technique) by a
factor that expresses the relationship between the signal
strength of the regions considered WMH by the segmentation
method and that of the other regions considered Bnormal^. This
might capture the more subtle features and thus provide a more
complete index of total brain injury fromWMH.We propose and
validate ametric to quantitatively express the white matter (WM)
damage to address this need.
Materials and methods
Subjects
We used brain MRI data from three observational studies: a
study of stroke mechanisms [18] and two studies of cognitive
ageing [19, 20] (http://www.lothianbirthcohort.ed.ac.uk/). From
the study of stroke, that initially enrolled 264 stroke patients
(mean age 66 years (SD 11 years)), we used data from 190
patients (78 women) who had two brain MRIs at mean
interval of 13 months, (SD 2 months). The median baseline
stroke severity (National Institute of Health Stroke Scale score)
was 2 (IQR 1–3) indicating mild stroke. From the studies of
cognitive ageing we used data from: a) 38 participants of the
Lothian Birth Cohort (LBC) 1921 that had anMRI scan at mean
age 92 years and WMH volume measures by two different
observers, one of them generated on two separate occasions,
and b) 444 participants of the LBC 1936 that had an MRI scan
at mean age 72.6 years (SD 0.7) and approximately three years
later. Formal written consent from all subjects and ethical ap-
proval was acquired from the Lothian Research Ethics
Committee (09/S1101/54, LREC/2003/2/29, REC 09/81101/
54), the NHS Lothian R+D Office (2009/W/NEU/14) and the
Multi-Centre Research Ethics Committee for Scotland
(MREC/01/0/56) and conducted according to the principles
expressed in the Declaration of Helsinki. The selection of the
datasets was only based on availability of complete data required
for the evaluation of the metric.
MRI acquisition
All structural brain MRI scans were obtained at the Brain
Research Imaging Centre, University of Edinburgh (http://
www.bric.ed.ac.uk) on a GE Signa Horizon HDx 1.5 T clinical
scanner (General Electric,Milwaukee,WI), equippedwith a self-
shielding gradient set and manufacturer-supplied eight-channel
phased-array head coil. The imaging protocols of all three prima-
ry studies have been published previously [17, 21]. The structural
sequences used in the generation of normal and abnormal WM
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segmentations were 3D T1-weighted and 2D axial T2 W, gradi-
ent echo and fluid attenuation inversion recovery (FLAIR) scans.
Calibration sequences, magnet shimming and visual quality as-
surance were performed during each scanning session.
The WM damage metric
TheWMdamage metric is equal to the proportion ofWMH in
the tissue where it can appear (i.e. brain tissue excluding the
cortex), weighted by the relative contrast of the FLAIR (or
T2 W) WMH with respect to that of the NAWM. If I is the
mean FLAIR (or T2W) signal intensity in a tissue type (e.g. in
the region occupied by WMH (IWMH) or in the region occu-
pied byNAWM (INAWM)), these can be calculated as per Eq. 1:
I ¼ ∑
n
i¼1I i
n
ð1Þ
where n is the total number of voxels that the tissue type
occupies (i.e. WMH or NAWM) and Iiis the FLAIR intensity
of the tissue type in the voxel i. Then, the WM damage is:
WMdamage
¼ IWMH−INAWM
INAWM
*
WMHvolume
WMHvolume þ NAWMvolume ð2Þ
Given that the intensity level of WMH on FLAIR is con-
ventionally reported to be at least 3 times the standard devia-
tion (SD) above the mean intensity of the NAWM [15, 22, 23]
(i.e., IWMH ≥ INAWM + 3*SDNAWMwith 0 ≤ SDNAWM ≤ (Imax
– Imin)/2) (see Supplementary Fig. S1), theWMdamage met-
ric will take positive real values between 0 and 1. For mini-
mum IWMH, if SDNAWM = 0, IWMH = INAWM, meaning that
WMdamage = 0, and if SDNAWM is maximum and Imin = 0,
then WMdamage = 3/2*(Imax/INAWM)*(WMHvolume/
(WMHvolume + NAWMvolume). However, for obtaining good
contrast in T2 W-based sequences INAWM ≤ 2/3*Imax [24],
which in the worst case scenario makes WMdamage dependent
on the second term of the Eq. (2) (once the first term would be
equal to 1) which reaches its maximum only in the hypothet-
ical case in which all tissue is abnormal. For maximum IWMH,
if the contrast between WMH and NAWM is maximum, the
first term of Eq. (2) is also 3/2*(Imax-Imin)/INAWM (former
case); and if the contrast between WMH and NAWM is min-
imum, the first term of the Eq. (2) is zero making
WMdamage = 0. The WM damage metric should be defined
as zero (0) in absence of WMH, i.e. when WMHvolume = 0.
Image analyses
We used NAWM and WMH masks obtained following the
validated procedures summarised in Table 1 and schemat-
ically represented in Fig. 1. Briefly, all image sequences
(from each study participant) were co-registered using
FSL-FLIRT [30] and mapped to native T2 W space.
WMH were extracted semi-automatically [17, 27] using
a validated multispectral colour-fusion-based segmenta-
tion method (MCMxxxVI, www.sourceforge.net/projects/
br ic1936) , which cons iders WMH signa ls tha t
Table 1. Image processing methods applied to each dataset
Primary study Number of
datasets used
Evaluation WMH segmentation method NAWM segmentation method
Stroke 190 Longitudinal semi-automatic
assessments
MCMxxxVI as per [17]. Intense and
less intense regions within the
WMH were separately segmented.
MCMxxxVI as per [17]
Lothian Birth
Cohort (LBC)
1921
38 Automatic cross-sectional
assessments and effect of
inter−/intra-observer differences
1) Automatic histogram-based
thresholding in FLAIR images [25]
2) Automatic histogram-based
thresholding in FLAIR followed
by manual editing (obs. 1, assess. 1)
3) Automatic histogram-based
thresholding in FLAIR followed
by manual editing (obs. 2)
4) Automatic histogram-based
thresholding in FLAIR followed
by manual editing (obs. 1, assess. 2)
Four-classes Multispectral
Gaussian clustering [26]
Lothian Birth
Cohort (LBC)
1936
237 Cross-sectional assessments
from two different WMH
segmentation methods
1) MCMxxxVI as per [15, 27] 1) MCMxxxVI as per [15, 27]
2) Automatic histogram-based
thresholding in FLAIR images
followed by manual editing [25]
2) Four-classes Multispectral
Gaussian clustering [26]
441 Longitudinal semi-automatic
assessments
Automatic histogram-based
thresholding in FLAIR images
followed by manual editing [25]
Probabilistic output from
FSL-FAST [28]
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simultaneously appear in all T2 W-based sequences, and/
or ful ly automatical ly us ing a his togram-based
thresholding in the FLAIR sequence [25]. All WMH bi-
nary masks were manually edited by trained observer(s)
(Table 1), who were blind to each-other’s results and to
the results from the first time-point when scans from the
second time-point were processed. When the multispectral
colour- fus ion method was appl ied , WMH were
subdivided into intense and less-intense lesions as per
[17] (Fig. 1) to analyse the influence of WMH severity
on various parameters. For longitudinal analyses, the
WMH volume change was calculated in two ways: 1)
subtracting the numeric WMH volume at baseline from
the WMH volume at follow-up and 2) subtracting previ-
ously co-registered WMH masks obtained at both time
points [17]. In the samples that provided data for longitu-
dinal analysis of WM changes, fractional anisotropy (FA)
and mean diffusivity (MD) were measured in WM regions
labelled as apparently normal [17] at baseline and follow-
up. Stroke lesions (old and recent) were excluded [17,
27]. The WMH binary masks generated from each proce-
dure were mapped onto the FLAIR images from which
they were derived, to obtain the FLAIR intensities within
each mask.
Binary masks of NAWM were obtained using two
multispectral segmentation methods (see Fig. 1): 1)
MCMxxxVI by thresholding the results of applying
minimum variance quantisation to the colour image
resulting from fusing in the red-green colour space T1-
and T2-weighted sequences (explained and validated in
[29]) and/or 2) Gaussian clustering into four clusters
[26] the multidimensional array formed by concatenat-
ing the normalised and brain-extracted images from
FLAIR, T1-, T2- and T2*-weighted sequences. Each
result was carefully visually inspected and manually
edited for accuracy. Given that the multispectral
Gaussian clustering did not perform well in the longitu-
dinal ageing sample (i.e. scans taken three years apart),
the binary mask of the NAWM was obtained in this
sample by thresholding the probabilistic NAWM output
from FSL-FAST [28]. This yielded consistent intra- and
inter-subject results throughout. The rest of the output
from FSL-FAST was not further used.
To evaluate the performance of our metric with re-
spect to clinical (visual) assessments, we used visual
ratings of WMH burden and WMH change, and small
vessel disease (SVD) burden. WMH burden was visual-
ly rated at each time point using Fazekas [31] scores.
We summed the periventricular and deep WM scores to
obtain a total Fazekas score that ranged from 0 to
6.Visual ratings scores of WMH change, obtained pri-
marily using the Prins scale [11], which assigns −1 (de-
crease), 0 (no change) or 1 (increase) to the perceived
WMH change in three periventricular and four deep
brain regions on each hemisphere, were summed to a
total score that ranged from −14 to 14. Total SVD
Fig. 1 Schematic representation
of the two basic NAWM and
WMH segmentation methods
applied to the datasets. 1) (yellow
panel) Multispectral segmentation
using colour fusion (MCMxxxVI,
[29]) fuses in the red-green colour
space T1- with T2-weighted, and
T2*-weighted with FLAIR,
applies minimum variance
quantisation to the fused image
and selects the quantised levels
corresponding toWM andWMH.
These are, then, combined to
separate the intense from the less
intense WMH and these from the
normal-appearing WM. 2) (blue
panel) Multispectral Gaussian
clustering [26] of the
multidimensional array formed by
concatenating the normalised and
brain-extracted FLAIR, T1-, T2-
and T2*-weighted images to
generate a WM likelihood
estimate that generates the priors
to threshold the FLAIR image and
extract the WMH
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scores were obtained as per Staals et al. (2014) [32].
All visual scores were generated by a neuroradiologist
with more than 25 years of experience.
Statistical analysis
We used analysis of covariance (ANCOVA) [33, 34]
with the follow-up WMH measurement as the outcome
and the baseline measurement and Prins as predictors to
evaluate the strength in the relation between quantitative
and visual assessments of WMH change, and univariate
linear regression, all programmed in SAS 9.3 (www.sas.
com). For completeness, we also analysed the change
scores [35] of WMH volume, Prins and WM damage.
For comparability with other existing literature [11,
27, 36] we also evaluated the bootstrapped non-
parametric correlations (Spearman ρ) between the
WMH volume and the burden of WM disease as
assessed visually from each method and compared them
with those obtained between the WM damage (i.e. the
new metric) and the same visual scores. The correla-
tions were obtained using the MATLAB Robust
Correlation Toolbox (http://sourceforge.net/projects/
robustcorrtool/) [37]. Paired Wilcoxon and t-tests and
Bland-Altman [38] plots were used to compare the out-
come of the assessments from different methods. We
also calculated the bootstrapped non-parametric correla-
tions between the WM damage and the average values
of FA and MD in NAWM. We hypothesised that the FA
will be lower (i.e. Spearman ρ will have negative
values) and the MD will be higher (i.e. Spearman ρ
will have positive values) in brains where the NAWM
is not so Bnormal^ (i.e. likely to have higher values of
WM damage overall) than in brains where the NAWM
is healthier.
Results
The characteristics and parameters of each sample, as relevant
to these analyses, are shown in Table 2.
WM damage vs. WMH volume
The results from the correlations between all cross-
sectional assessments are shown in Table 3 and
Supplementary Table S4. In general, all correlations be-
tween cross-sectional quantitative measurements (i.e.
WMH volume and WMH damage) and visual scores
(i.e. total Fazekas, total SVD score) were strong and
significant. WM volume and WM damage were also
significantly and strongly correlated (Spearman
ρ > =0.97, p < 0.0001) in all cases.
Table 2 Characteristics of the samples involved in the evaluation of the WM damage metric
Sample \ Parameter Longitudinal samples Cross-sectional samples
Stroke LBC1936 LBC1936 (two WMH
segmentation methods)
LBC1921 (Inter−/intra-observer
differences in WMH segmentation)
N (gender) 190 (112 M, 78 W) 441 (198 M, 243 W) 237 (120 M, 117 W) 38 (20 M, 18 W)
Age (years) 66 (SD 11)
at baseline
72.6 (SD 0.7)
at baseline
72.6 (SD 0.7) 92.1 (SD 0.34)
Total Fazekas scores baseline† 2 (2) 2 (1) 2 (1) 5 (3)
SVD scores baseline† 1 (2) 1 (2) 1(1) 2 (2)
Total Prins scores† 0 (4) 0 (2) N/A N/A
Average WMH volume
(ml)†
Baseline scan:
12.7 (28.6)
Follow-up scan:
15 (26.7)
Baseline scan:
8.1 (11.5)
Follow-up scan:
11.5 (16.3)
Method 1:
9.8 (14.8)
Method 2:
9.2 (12.1)
M1: 33.6 (38.1)
M2: 34.9 (38.6)
M3: 31.7 (41.8)
M4: 32.1 (42.5)
Average % WMH vol in ICV† Baseline scan:
0.86 (1.95)
Follow-up scan:
0.98 (1.731)
Baseline scan:
0.57 (0.79)
Follow-up scan:
0.78 (1.13)
Method 1:
0.70 (1.03)
Method 2:
0.63 (0.84)
M1: 2.4 (2.5)
M2: 2.5 (2.6)
M3: 2.3 (2.9)
M4: 2.3 (3.0)
Average WM damage† Baseline scan:
0.0082 (0.025)
Follow-up scan:
0.01 (0.028)
Baseline scan:
0.0065 (0.01)
Follow-up scan:
0.0094 (0.016)
Method 1:
0.0075 (0.012)
Method 2:
0.0073 (0.011)
M1: 0.033 (0.051)
M2: 0.033 (0.051)
M3: 0.032 (0.052)
M4: 0.032 (0.052)
Legend: N/A: not applicable, cross-sectional data; † : Values given are median (IQR); Method 1: MCMxxxVI, multispectral colour fusion-based
segmentation method; Method 2: FLAIR thresholding-based segmentation method; M1-M4 refer to measurements 1 to 4 in the LBC1921 sample
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WMH damage using WMH masks obtained from two
different segmentation methods
The median WMH volume obtained from the two segmenta-
tion methods applied to the LBC 1936 sample of 237 individ-
uals (samples characteristics in Tables 1 and 2) was: 9.76 ml
(IQR 14.79 ml) with the multispectral method (i.e.
MCMxxxVI) and 9.16 ml (IQR 12.12 ml) with the
histogram-based FLAIR thresholding method. These two
measurements were not statistically significantly different
from each other (p = 0.5623). TheWMdamage obtained from
both methods was: median value of 0.0075 for MCMxxxVI
and 0.0073 for the histogram-based FLAIR thresholding
method) when calculated using FLAIR images; and 0.013
for both methods when it was calculated using T2 W images.
WM damage measurements did not differ significantly be-
tween methods (p = 0.9273). Correlations of both types of
measurements (i.e. WMH volume and WM damage) with
Fig. 2 Bland-Altman plots
showing the agreement between
all four measurements of WM
damage (above) and all four
WMH volume measurements
(below). Blue rhombi compare
measurement 1 with 2, pink
crosses compare measurements 2
and 3, orange squares evaluates
the agreement of measurement 1
against 3, grey triangles compare
measurements 1 and 4, green
circles 3 and 4 and blue stars
compare measurements 2 and 4.
Ordinates of both graphs are
expressed in percentage with
respect to the average values for
comparability of the results
between both metrics. The WM
damage metric shows better
agreement than theWMHvolume
measurements, between the 4
assessments on all cases and in
general (mean % differences:
4.26[−14.43 22.95](%) for the
WM damage metric vs.
5.35[−18.75 29.45](%) for the
WMH volume measurements)
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total Fazekas scores were all significant (p < 0.0001) regard-
less of whether T2 W or FLAIR signal were used in the anal-
ysis and which of the WMH segmentation methods were used
(Table 3).
Influence of inter−/ intra-observer variations in theWMH
/ WM damage assessments
The average median WMH volume on the ageing sample that
provided data for this analysis (i.e. LBC 1921) was 33.08 ml
(average IQR 40.24 ml). The average difference between the
four WMH volume measurements (see Table 1) was median
5.59% (IQR 5.88%), whereas the average difference between
the four WM damage metrics generated from these four as-
sessments was median 3.26% (IQR 2.76%) when the signal
intensity was assessed in the FLAIR images and 5.72% (IQR
5.32%) when the signal intensity was assessed in the T2 W
images. Figure 2 and Supplementary Table S1 show the
Bland-Altman analyses to evaluate agreement between all
measurements involved using FLAIR images to assess the
signal intensity. The WM damage metric shows better agree-
ment than the WMH volume measurements, between the 4
assessments on all cases and in general (mean % differences:
4.26[−14.43 22.95](%) for the WM damage metric vs.
5.35[−18.75 29.45](%) for the WMH volume measurements).
Similar results were observed using T2 W to quantify the
signal intensity. Figure S2 (Supplementary material) shows
the four measurements of WMH volume and WM damage
for all the 38 datasets of this sample using FLAIR images to
assess the signal intensity. Non-parametric correlations
(Spearman ρ) between the WM damage metric and visual
rating scores were all significant (p < 0.001) and slightly stron-
ger than between WMH volume and visual ratings (Table 3
and Supplementary Table S4).
WM damage progression vs. longitudinal WMH
change
The net volume of WMH increased (median 2.6 ml (IQR
4.7 ml)) over 3 years in the ageing sample, and at approxi-
mately 1 year in the stroke sample (median 1.4 ml (IQR
6.9 ml)) (baseline and follow-up volumes in Table 2). The
total Prins visual ratings ranged from −12 to +10 in stroke
patients, and correlated significantly with the progression of
WM damage expressed by our new metric (Spearman ρ
Fig. 3 Axial FLAIR slice of the
baseline and follow-up scans of a
stroke patient, in which the total
WMH volume changed from
4.6 ml to 11 ml and the WM
damage metric changed from
0.0036 to 0.0058. The intense
WMH increased 0.7 ml (i.e. from
2 to 2.7 ml), whereas the less
intense WMH (arrowed)
increased 5.7 ml (i.e. from 2.6 to
8.3 ml). Despite both images been
acquired with equal scanning
parameters, the contrast between
the subtle WMH and the
Bnormal^ WM differs in both
scans influencing the results of
the segmentation. Below are
shown the WMH masks overlaid
in both scans
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between WM damage change and Total Prins = 0.5,
p < 0.0001, for both samples) (Tables S2 and S3). In both
samples, the follow-up WM damage was highly related to
total Prins score even when adjusted for baselineWMdamage
(ANCOVA, p < 0.0001): the increase in the logarithm of WM
damage per unit change in total Prins score was 0.074 (95%CI
[0.054 0.093]) in the stroke sample, and 8.67 × 10−4 (95%CI
[8.05 × 10−49.30 × 10−4]) in the ageing sample. However, in
the stroke sample total Prins score and WMH volume change
(calculated by subtracting the WMH volumes at both time
points) were not correlated (Table S2).
Further analysis of WMH severity in the stroke patients
revealed that the net WMH volume change was mainly driven
by the change in the volume of less intenseWMH (Fig. 3) (i.e.
the correlation between net WMH volume change and the
change in the less intense WMH was stronger (Spearman ρ
0.90, p < 0.0001) than with the change in the intense WMH
(Spearman ρ 0.46, p < 0.0001)). On the contrary, total Prins
scores were more closely related to the change in the volume
of the intense WMH (Table S2). Indeed, the follow-up intense
WMH volume was significantly associated to total Prins score
(p = 0.0079), with an increase of 4.42 ml per unit change in
total Prins score (95%CI [1.17 7.67]) after adjusting for base-
line intense WMH volume. An univariate regression analysis
of the spatial change in WMH (i.e. obtained from the subtrac-
tion of the baseline and follow-up WMH masks, not from the
subtraction of the volumetric measurements) in relation to
Total Prins in this sample showed a logarithm of the total
change in WMH increasing in 0.11 per unit change in Total
Prins, (95%CI [0.041 0.18], p = 0.0019) and no association
between the change of the intense WMH and Total Prins
(p = 0.57) (Fig. 4).
WM damage and WMmicrostructure (FA, MD)
In the NAWM regions, WM damage was negatively correlat-
ed with average values of FA (Spearman ρ ≈ −0.4 for the
LBC1936 sample and ≈ −0.55 for the stroke sample) and
positively correlated with average values of MD (Spearman
ρ ≈ 0.3 for the LBC1936 sample and ≈ 0.6 for the stroke
sample) in all cases at baseline and follow-up, (all correlations
p < 0.0001).
Analysis of possible confounds
All evaluations were repeated considering the WMH volumes
before and after correcting for head size (Table 3 and
Supplementary Tables S2 to S4). Paired non-parametric
Wilcoxon and t-tests showed that despite the median WMH
volume before and after adjusting by head size (i.e. intracra-
nial volume (ICV)) being significantly different from each
other (p < 0.0001), and the percentage change of WMH in
ICV being significantly different from the percentage change
of WMH volume (p < 0.0001) on all samples evaluated, the
strength and significance of all correlations and associations
were unaltered (see cells in grey in Supplementary Tables 2
and 3), and their correlation was 0.998 [0.997 0.999] in the
stroke sample and 0.996 [0.994 0.997] in the ageing sample,
significant in both samples (p < 0.0001).
Analyses were repeated using the WM damage calculated
using T2 W images. In measurements labelled as 2 (M2 in
Table 2) in the LBC1921 sample, the WM damage calculated
using FLAIR differed from when it was calculated using
T2W with borderline significance (p = 0.047), but in general,
Fig. 4 The change in WMH volume, after being log transformed, was
modestly but significantly associated with Total Prins (left) in the stroke
sample. However, the spatial change (obtained from the subtraction of the
baseline and follow-up WMH masks, not from the subtraction of the
volumetric measurements) observed in the regions of intense WMH
[17], was not associated with Total Prins (right)
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this difference was not significant (p > 0.05). The strength in
the Spearman correlations between the WM damage metric
calculated from T2 W or FLAIR and the visual ratings (i.e.
Fazekas and SVD scores) was the same up to the second
decimal point for large samples, and differed in the absolute
range of 0.02 in the small sample (LBC 1921, n = 38) except
when the WM damage obtained from T2 W and FLAIR dif-
fered with borderline significance (Spearman ρ correlations
with visual ratings differed in 0.05) (see Supplementary
Table S5). The significance in the correlations was not altered.
Discussion
There is a need to harmonise methods for processing com-
mon features such as WMH on imaging. We present a WM
damage metric that expressed the degree of WM disease on
conventional structural MRI and was robust to variations in
image processing methods used to quantify Bnormal^ and
Babnormal^WM.Although we have focused here onWMH
of presumed vascular origin, this metric could be used to
harmonise results in studies of other neurological diseases
that present WMH on MRI. Once NAWM and WMH re-
gions are defined on brain MRI, the WM damage metric is
very simple to compute. Only T2 W and FLAIR have been
tested and proposed for generating this metric because WM
disease is identified on structural MRI by these two se-
quences, specifically WMH are defined as showing
Bhyperintensity on T2-weighted images such as fluid-
attenuated inversion recovery^ [1]. The value of the WM
damage metric is not absolute. It depends on the type and
parameters of the sequence used (i.e. T2 Wor FLAIR), as it
is calculated using intensity (i.e. not quantitative) images.
However, the associations between WMH burden using
this parameter and neuroradiological assessments of
WMH burden and WMH change may remain invariant de-
spite variations in the scanning protocols and/or sequence
used to compute it. Given the variety of sequences and
scanning parameters from the several MRI scanner manu-
facturers, this fact gives additional strength.
Whilst the correlations between the new metric and
visually assessed WMH burden (i.e. Fazekas scores) are
comparable with those between the WMH volumetric
measurements and the visual scores, the results suggest
that the change (i.e. longitudinal change, evolution) in
WMH burden is better and more consistently represented
by this metric than by conventional volumetric methods.
Of particular interest is the consistency in the associations
between the neuroradiological visual assessments of lon-
gitudinal WMH changes (i.e. Prins visual scores) and the
difference in the WM damage metric (i.e. WM damage
change). On the other hand, assessments of WMH volume
change are not always straightforward and therefore
volumetric and visual assessments of WMH change do
not always agree. Depending on whether the WMH vol-
ume change is calculated, e.g. by subtracting the WMH
volumes obtained at different time points or analysing the
spatial change, its association with the visual scores can
differ, as in the longitudinal samples we analysed.
Analysing the spatial change of the regions labelled as
WMH would be the most reasonable approach, but image
co-registration in the presence of tissue loss and shape
distortions in the brain parenchyma (e.g. brain images of
stroke patients) can be challenging and misleading.
The robustness of the new metric to differences in image
processing methods and its sensitivity to capture subtle and
severe white matter damage confer it advantage over the use
of WMH volume in the assessment of longitudinal WM
changes. In addition, analysis of tissue microstructure in re-
gions labelled as Bnormal^ showed agreement with the degree
of WM damage expressed by the proposed metric. We think
that using this metric together with the conventional indicators
of disease currently available will be a step forward in the
harmonisation of study results, computational diagnostics
and Bbig data^ analyses. Further evaluation using images from
other diseases (e.g. multiple sclerosis, different types of de-
mentia, etc.) is needed.
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